查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466810

細胞治療市場：按細胞類型、治療類型、應用和最終用戶分類 - 2024-2030 年全球預測

Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年細胞治療市場規模為86.6億美元，預計2024年將達96億美元，2030年將達179.1億美元，複合年成長率為10.93%。

細胞治療市場包括透過活細胞管理來治療、緩解和預防疾病的產品和技術的研究、開發、製造和商業化。對再生醫學的需求不斷成長和細胞治療的進步主要推動了細胞治療市場的成長。研發投入不斷增加，製藥公司和研究機構之間的合作正在加速細胞治療產品的研發。此外，支持性法律規範和突破性治療方法的快速核准指定是市場的關鍵成長動力。然而，細胞治療市場面臨一些限制，例如治療高成本、製造流程複雜以及可能延遲市場進入的嚴格監管要求。此外，與細胞療法的儲存、運輸和保存期限相關的挑戰也是市場成長的主要挑戰。此外，CRISPR/Cas9等基因編輯技術的突破為標靶細胞療法開闢了新途徑，有可能為以前無法治療的疾病提供精準醫療解決方案。擴大採用 3D 生物列印和人工智慧來最佳化細胞治療生產，這為未來的市場擴張帶來了巨大的希望。

主要市場統計
基準年[2023] 86.6億美元
預測年份 [2024] 96億美元
預測年份 [2030] 179.1億美元
複合年成長率（%） 10.93%

細胞類型：幹細胞治療應用的進展

分化細胞是已經成熟以在體內執行特定功能的特化細胞。分化細胞因其高度專業化和替換丟失或損壞的同源細胞的有效性而被用於細胞治療。分化細胞的主要優點是它們比幹細胞形成腫瘤的風險更低，這使得它們非常適合直接治療應用。幹細胞是未分化的細胞，可以進化成各種類型的細胞，在再生醫學方面具有巨大的潛力。幹細胞因其獨特的自我更新和分化成多種細胞類型的能力而特別適合廣泛的治療應用。

治療類型：擴大採用自體細胞療法進行個人化醫療

同種異體細胞療法涉及將來自基因不同的健康捐贈者的細胞移植到患者體內。同種異體細胞療法並非針對個別患者，可以大量生產，並且通常被稱為「現成的」。當患者需要立即治療且沒有時間收穫和擴增細胞時，優選同種異體細胞療法。自體細胞療法源自於患者自身的細胞，這些細胞被收穫、發育、必要時進行修飾，然後重新引入患者體內。自體細胞療法是個人化醫療的理想型態，因為它是為每位患者量身定做的。對於需要患者自身細胞材料以消除免疫排斥可能性的治療，通常選擇自體細胞療法。

應用：細胞療法在皮膚科應用的進展

自體免疫疾病的細胞療法旨在提供可調節或重置免疫系統的創新療法。患有自體免疫疾病的患者需要能夠提供長期緩解的治療方法，並且不會產生與長期免疫抑制相關的副作用。再生細胞療法為先前治療選擇有限的自體免疫疾病提供了潛在的治療方法。細胞療法在皮膚科的應用主要解決燒燙傷患者的皮膚修復、手術後重組、慢性傷口和美容皮膚再生。對於燒燙傷和慢性傷口的患者，細胞療法可以加速癒合並減少疤痕組織的形成。皮膚病學和美容學應用利用再生能力來改善皮膚的外觀和健康。肌肉骨骼系統的細胞療法針對骨關節炎、骨折和軟骨修復等疾病。細胞療法的重點是利用幹細胞的再生能力來修復和再生受損的組織。 CAR-T是治療白血病、淋巴瘤和多發性骨髓瘤等癌症的突破性方法。

最終使用者：細胞療法在醫院和診所疾病管理的多種應用

作為治療解決方案的開發商和提供者，生物技術和製藥公司是細胞治療市場的主要最終用戶。生技公司專注於發現、開發和商業化針對多種疾病的細胞療法，包括癌症、自體免疫疾病和遺傳性疾病。細胞科學的進步、對創新治療方法的需求以及成功治療方法帶來的巨大經濟回報的潛力推動了他們基於需求的偏好。醫院和診所是市場區隔的另一個重要部分，因為它們對於向患者進行細胞治療至關重要。對特定細胞療法的偏好通常取決於療效、安全性、成本效益和報銷政策。作為大型醫療網路或學術機構一部分的醫院，由於其內部專業知識和基礎設施，可能能夠更好地採用新型細胞療法。研究機構透過進行基礎研究和轉化研究並開發這一領域，在最終用戶環境中發揮基礎性作用。研究機構正在努力了解疾病機制並透過津貼和內部資助計劃開發創新治療方法。

區域洞察

在美洲，美國和加拿大憑藉著廣泛的研究、大量的投資以及生物技術和製藥巨頭的積極參與，在細胞治療方面處於領先地位。該地區的監管框架能夠快速審查新型細胞療法，並加速將新治療方法推向市場的進程。歐洲國家正在透過公共和私營部門的各種夥伴關係和資助計劃展示合作研究方法。歐盟的客戶行為受到對國家資助的醫療保健系統的強烈偏見的影響，從而影響了細胞療法的獲取和負擔能力。在中東和非洲，雖然以色列、阿拉伯聯合大公國和沙烏地阿拉伯等國家在這一領域取得了長足的進步，但許多非洲國家仍在發展這一領域的能力，並且有著相似的外表。在亞太地區，中國、印度和日本政府啟動了多項投資和改革，以加速該地區的細胞治療研究和商業化。該地區癌症和遺傳疾病的盛行率正在增加，對基於細胞的疾病管理療法的需求也在顯著增加。

FPNV定位矩陣

FPNV定位矩陣對於評估細胞治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對細胞治療市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該細分市場競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動和突破性產品開發的智力見解。

本報告解決了以下關鍵問題：

1. 細胞治療市場的市場規模與預測是多少？

2.在細胞治療市場的預測期間內，有哪些產品、細分市場、應用和細分市場需要考慮投資？

3. 細胞治療市場的技術趨勢和法規結構是什麼？

4.細胞治療市場主要廠商的市場佔有率是多少？

5. 進入細胞治療市場的合適型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 政府增加對生物技術創新的投資和細胞療法的核准率
      • 改善細胞治療供應鏈
    • 抑制因素
      • 與幹細胞移植相關的副作用
    • 機會
      • 嵌合體抗原受體 T 細胞 (CAR-T) 療法以及 ESC（胚胎幹細胞）和 iPSC（誘導性多功能幹細胞）在癌症治療中的應用取得進展
      • 增加幹細胞在治療神經系統疾病的應用
    • 任務
      • 與使用幹細胞相關的倫理和藥理學問題
  • 市場區隔分析
    • 細胞類型：幹細胞治療用途的進展
    • 治療類型：在個人化醫療中擴大採用自體細胞療法
    • 應用：細胞療法在皮膚科應用的進展
    • 最終使用者：細胞療法在醫院和診所疾病管理的多種應用
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章細胞治療市場：依細胞類型

  • 介紹
  • 分化細胞
  • 幹細胞

第7章細胞治療市場：依治療類型

  • 介紹
  • 同種異體療法
  • 家庭治療

第8章細胞治療市場：依應用分類

  • 介紹
  • 自體免疫疾病
  • 皮膚科
  • 肌肉骨骼治療
  • 腫瘤學

第9章細胞治療市場：依最終使用者分類

  • 介紹
  • 生物技術和製藥公司
  • 醫院和診所
  • 研究機構

第10章美洲細胞治療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞治療市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲細胞治療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-433AB1DC28D4

[192 Pages Report] The Cell Therapy Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 9.60 billion in 2024, at a CAGR 10.93% to reach USD 17.91 billion by 2030.

The cell therapy market encompasses the research, development, manufacturing, and commercialization of products and techniques aimed at treating, mitigating, or preventing diseases by administering living cells. The escalating demand for regenerative medicine and advancements in cellular therapeutics primarily drives the growth of the cell therapy market. The rising investment in research and development and collaborative efforts between pharmaceutical companies and research institutions have accelerated the pipeline for cell therapy products. Furthermore, supportive regulatory frameworks and the designation of fast-track approvals for groundbreaking therapies have been crucial growth stimulants for the market. However, the cell therapy market faces several limitations, such as the high cost of therapies, intricate manufacturing processes, and stringent regulatory requirements, which may slow down market entry. Issues related to the preservation, transport, and shelf-life of cell therapies also present substantial challenges in the market growth. Moreover, breakthroughs in gene editing technologies such as CRISPR/Cas9 have opened new avenues for targeted cell therapies, which could offer precision medicine solutions for previously untreatable conditions. The increasing adoption of 3D bioprinting and artificial intelligence for optimizing cell therapy production holds significant promise for future market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 8.66 billion
Estimated Year [2024] USD 9.60 billion
Forecast Year [2030] USD 17.91 billion
CAGR (%) 10.93%

Cell Type: Advancements in stem cells for therapeutic applications

Differentiated cells are specialized cells that have matured to perform a specific function in the body. Differentiated cells are used in cell therapy due to their high specialization and efficacy in replacing lost or damaged cells of the same type. The significant advantage of differentiated cells lies in their lower risk of tumor formation than stem cells, making them highly preferable for direct therapeutic applications. Stem cells are undifferentiated cells that can evolve into various types of cells and hold enormous potential for regenerative medicine. Stem cells are particularly used for their unique capabilities to self-renew and differentiate into multiple cell types, making them suitable for a broad range of therapeutic applications.

Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines

Allogeneic cell therapies involve transplanting cells from a healthy, genetically different donor into a patient. Allogeneic cell therapies are not specific to the individual patient and can be manufactured in larger batches, often called "off-the-shelf" products. Allogeneic therapies are preferred when patients require immediate treatment and do not have time to harvest and expand their cells. Autologous cell therapies are derived from the patient's own cells, which are collected, developed, modified if needed, and then reintroduced into the patient's body. Autologous cell therapies are uniquely tailored to each patient, making them an ideal form of personalized medicine. Autologous therapies are often the choice for treatments requiring the patient's own cellular material to eliminate chances of immunological rejection.

Application: Advancements in dermatological applications of cell therapies

Cell therapies for autoimmune diseases aim to provide innovative treatments that can modulate or reset the immune system. Autoimmune patients require treatments that can provide long-term relief without the adverse effects associated with long-term immunosuppression. Regenerative cell therapies offer potential cures for autoimmune disease conditions that previously had limited treatment options. The application of cell therapies in dermatology primarily addresses skin regeneration for burn victims, reconstruction following surgery, chronic wounds, and cosmetic skin rejuvenation. For patients suffering from burns or chronic wounds, cell therapies accelerate healing and reduce scar tissue formation. Dermatological & cosmetic applications leverage regenerative capabilities to improve skin appearance and health. Cell therapies in the musculoskeletal domain target conditions such as osteoarthritis, bone fractures, and cartilage repair. Cell therapies focus on harnessing the regenerative potential of stem cells for repair and regenerate damaged tissues. Cell therapy plays a critical role in oncology, with CAR-T cell therapy being a revolutionary approach in cancer treatment, including leukemia, lymphoma, and multiple myeloma.

End-User: Diverse applications of cell therapies in hospitals and clinics for disease management

Biotechnology and pharmaceutical companies are primary end-users in the cell therapy market as developers and providers of therapeutic solutions. Biotechnology companies focus on the discovery, development, and commercialization of cell therapies for a variety of diseases, including cancer, autoimmune disorders, and genetic diseases. Their need-based preference is driven by advancements in cellular science, the demand for innovative treatments, and the potential for significant financial returns from successful therapies. Hospitals and clinics represent another crucial segment in the cell therapy market, as they are essential for administering cell therapies to patients. The preference for specific cell therapies often depends on efficacy, safety profiles, cost-effectiveness, and reimbursement policies. Hospitals affiliated with large healthcare networks or academic institutions may have a greater capacity for adopting novel cell therapies due to in-house expertise and infrastructure. Research institutes serve a fundamental role in the cell therapy end-user landscape by conducting basic and translational research to advance the field. Research institutes seek to understand disease mechanisms and develop innovative therapies through grant-funded or internally-financed projects.

Regional Insights

In the Americas region, the United States and Canada lead in cell therapy advancements, driven by significant research, heavy investment, and active participation from biotechnological and pharmaceutical giants. The regulatory framework in the region allows for an expedited review of novel cell therapies, hastening up the process of bringing new treatments to market. The European countries exhibit a cooperative approach towards cell therapy research, with various cross-country partnerships and funding programs supported by public and private sectors. Customer behavior in the EU is influenced by a strong predisposition towards state-funded healthcare systems, which affects access to and affordability of cell therapies. The Middle East and Africa (MEA) present a diverse picture, with countries such as Israel, UAE, and Saudi Arabia taking strides in cell therapy, while many African nations are still developing capabilities in this area. In the APAC region, the governments in China, India, and Japan have initiated several investments and reforms to fast-track local cell therapy research and commercialization. The rising prevalence of cancers and genetic diseases in the region is significantly increasing the need for cell-based therapies for disease management.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Astellas Pharma Inc., Athersys, Inc., BioNTech SE, Bone Therapeutics SA, Bristol-Myers Squibb Company, Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., Lonza Group Ltd., Medipost Co., Ltd., Mesoblast Ltd., Novartis AG, NuVasive, Inc., Pfizer Inc., Sartorius AG, Smith & Nephew PLC, Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, TegoScience, Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Cell Type
    • Differentiated Cell
    • Stem Cell
  • Therapy Type
    • Allogenic Therapies
    • Autologous Therapies
  • Application
    • Autoimmune Diseases
    • Dermatology
    • Musculoskeletal Therapies
    • Oncology
  • End-User
    • Biotechnology and Pharmaceutical Companies
    • Hospitals and Clinics
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Market?

4. What is the market share of the leading vendors in the Cell Therapy Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
      • 5.1.1.2. Improvements in Cell Therapy Supply Chain
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects Related to the Stem Cell Transplant
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
      • 5.1.3.2. Increasing Use of Stem Cells for the Treatment of Neurological disorders
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Cell Type: Advancements in stem cells for therapeutic applications
    • 5.2.2. Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
    • 5.2.3. Application: Advancements in dermatological applications of cell therapies
    • 5.2.4. End-User: Diverse applications of cell therapies in hospitals and clinics for disease management
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Cell Therapy Market, by Cell Type

  • 6.1. Introduction
  • 6.2. Differentiated Cell
  • 6.3. Stem Cell

7. Cell Therapy Market, by Therapy Type

  • 7.1. Introduction
  • 7.2. Allogenic Therapies
  • 7.3. Autologous Therapies

8. Cell Therapy Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Dermatology
  • 8.4. Musculoskeletal Therapies
  • 8.5. Oncology

9. Cell Therapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Biotechnology and Pharmaceutical Companies
  • 9.3. Hospitals and Clinics
  • 9.4. Research Institutes

10. Americas Cell Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pluri Launches New Cell Therapy CDMO Division
    • 13.3.2. Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR
    • 13.3.3. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CELL THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CELL THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL THERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 374. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023